Latest News

On November 26, 2025, the Société québécoise du cannabis will begin marketing cannabis vaping products. Since 28% of Quebec consumers already use this method of consumption, this new offering aims to divert them from the illicit market and reduce the risks associated with unregulated products that are potentially harmful or dangerous.

The SQDC has just published its results for the second quarter of 2025-2026. The bottom line: net income of $30.5 million and $67.6 million in tax revenue (with $48.3 million paid to the Quebec government and $19.3 million to the federal government), including $59.9 million paid to the Addiction Fund to support prevention, research, and harm reduction related to psychoactive substances.

According to Statistics Canada data, in 2024, the country recorded a 31% drop in drug-related crime rates compared to 2019, the first full year of data following the legalization of non-medical cannabis.

Seven years after legalization, Quebec's hemp and cannabis ecosystem has proven its strength and demonstrated one thing: when innovation meets rigor, economic value is created, public health is improved, and an industry capable of supporting the most ambitious projects is built.

The Spanish government has passed a decree authorizing the medical use of THC-based drugs, prescribed only by hospital doctors. Priority beneficiaries will be patients suffering from severe epilepsy, spasticity related to multiple sclerosis, nausea due to chemotherapy, or chronic pain resistant to conventional treatments.

The European Union launches Cannapol, a tool developed by the European Union Drugs Agency (EUDA) to support Member States in implementing policies on recreational cannabis.

In a post on Truth Social, US President Donald Trump recognizes that CBD helps slow the progression of certain diseases and is an alternative to medication for the elderly. This is his strongest statement in favor of cannabis-related products since he took office in January 2025.

Stating his desire to “allow the legal market to continue to grow, ensure consumers have access to safe products, and ensure that our local communities benefit,” Governor Newsom announced a reduction in excise tax effective October 1. The tax will return to its original rate of 15%.

According to a recent report by the New York State Office of Cannabis Management, cumulative sales since legalization now exceed $2 billion, with nearly $1 billion generated since the beginning of the year.

Analytical chemists at Stellenbosch University have identified the presence of flavoalkaloids in cannabis leaves, a rare class of phenolic compounds. Phenolics—and flavonoids in particular—are attracting considerable interest in the pharmaceutical industry due to their recognized antioxidant, anti-inflammatory, and anti-carcinogenic properties.

In 2024, the cannabis industry contributed $16 billion to Canada's GDP and supported nearly 227,000 jobs across the country. As Beena Goldenberg, CEO of Organigram Global, explains, “The legal cannabis sector is a high value-added industry that already meets the Prime Minister's vision for a unique Canadian economy: an integrated, high value-added national industry, built in Canada, employing Canadians, and competitive on a global scale.”

Between 2021 and 2023, cannabis use among Americans over the age of 65 jumped by 46%. According to a study published in the medical journal JAMA Internal Medicine, there has also been a significant increase in the number of users from high-income households in this age group.